StockWatch
·
Biotechnology: Pharmaceutical Preparations
AGM/EGMMay 20, 2026, 04:23 PM

Alkermes Shareholders Approve 5.9M Share Increase for 2018 Stock Plan

AI Summary

Alkermes plc shareholders approved amendments to the 2018 Stock Option and Incentive Plan, increasing the number of ordinary shares authorized for issuance by 5,900,000. At the Annual Meeting, shareholders also elected nine directors, approved executive officer compensation in a non-binding advisory vote, and ratified PricewaterhouseCoopers LLP as the independent auditor. Additionally, they renewed the Board's authority to allot and issue shares and to disapply statutory pre-emption rights under Irish law.

Key Highlights

  • Shareholders approved amendments to the 2018 Stock Option and Incentive Plan, increasing authorized shares by 5,900,000.
  • The 2018 Plan was approved with 128,147,910 votes for and 12,952,836 votes against.
  • Nine directors were elected to the Board, each receiving over 133 million "For" votes.
  • Executive officer compensation was approved in a non-binding vote with 139,234,176 votes for.
  • PricewaterhouseCoopers LLP was ratified as independent auditor with 146,222,286 votes for.
  • Board authority to allot shares was renewed with 148,661,934 votes for.
  • Board authority to disapply pre-emption rights was renewed with 146,903,611 votes for.